Latest for X-Linked Hypophosphatemia
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial statusNo longer enrolling. Early Check: Expanded Screening in Newborns (RTI International)ClinicalTrials.gov
More about X-Linked Hypophosphatemia
Traditionally, XLH was managed with phosphate supplements and high-dose vitamin D, requiring frequent monitoring and multiple daily doses. Targeted therapy with burosumab offers a fundamentally different approach by blocking excess FGF23, the hormone behind the phosphate loss, rather than replacing phosphate by mouth. This treatment leads to better phosphate levels, improved bone healing, reduced pain, and improved physical function.
Keep reading about X-Linked Hypophosphatemia
Early diagnosis and treatment make a significant difference in preventing severe bone deformities and improving quality of life. Many patients experience substantial improvements in mobility and pain levels when started on appropriate therapy.
What are the symptoms of X-Linked Hypophosphatemia?
These are common symptoms of X-Linked Hypophosphatemia, and how strong they are varies from person to person.
- Bowed legs or knee deformities
- Short stature or slowed growth
- Bone and muscle pain or weakness
- Delayed walking or mobility problems in children
- Dental problems including recurrent tooth abscesses
- Joint stiffness and fractures in adults
Who gets X-Linked Hypophosphatemia?
XLH is caused by mutations in the PHEX gene on the X chromosome and typically appears in infancy or early childhood, usually between 12 and 18 months when children begin weight-bearing activities. Females with 1 PHEX variant usually have signs and symptoms similar to those in males, according to MedlinePlus Genetics, and severity varies widely even within a family. It affects people of all ethnicities.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for X-Linked Hypophosphatemia?
There are currently 2 FDA-approved medications for X-Linked Hypophosphatemia.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for X-Linked Hypophosphatemia treatment
Charity funds and drugmaker programs for X-Linked Hypophosphatemia, checked at the source.
- From a charity · The Assistance FundHypophosphatemia fundOpen
Pays for: Copays, coinsurance, deductibles and other health-related expenses.
Every program and fund for X-Linked Hypophosphatemia, by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for X-Linked Hypophosphatemia
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted X-Linked Hypophosphatemia resources
Reputable organizations and medical references for learning more about X-Linked Hypophosphatemia, including disease registries, foundation resources, and clinical guidelines.